FDA

Researchers are continually looking for effective drug treatments for Alzheimer’s patients, but they often face significant challenges in getting them approved by the Food and Drug Administration (FDA). However, the agency recently announced it will be changing its guidelines to ease the approval process and potentially change the face of Alzheimer’s care, The New York Times reports. 

Read More